Laboratory Procedure – Page 2

UDENYCA, Coherus Biosciences, supply interruption, biosimilar, pegfilgrastim, Neulasta, cancer treatment, white blood cell count, pharmaceutical supply chain.

Lilly’s Once-Weekly Insulin Efsitora Alfa Achieves Non-Inferiority in Four Phase 3 Trials

9 months ago talkbio0Tagged Administration occupational activities, Alfa, Diabetes, efsitora, Eli, Eli Lilly, Hemoglobin A1c measurement, Insulin, insulin therapy, non-inferiority, once-weekly, Phase 3 trials

Eli Lilly, efsitora alfa, once-weekly insulin, diabetes management, Phase 3 trials, non-inferiority, A1C reduction, insulin therapy.

Women Breaking Barriers in Drug Development: Celebrating Leadership and Innovation

9 months ago talkbio0Tagged Drug Development, Drug Industry, equity, Gender, innovation, Leadership, Scanning Transmission Electron Microscopy Procedures, Woman

Women in drug development, gender equity, STEM, pharmaceutical industry, leadership, innovation

Novo Nordisk Unveils Enhanced Cardiovascular Benefits of Semaglutide in Post-Hoc Analysis

9 months ago talkbio0Tagged Analysis of substances, Cardiovascular system, Diabetes, Nordisk, Obesity, outcomes, semaglutide

Semaglutide, Cardiovascular Outcomes, Obesity, Type 2 Diabetes, Novo Nordisk, Post-Hoc Analysis

UCB Divests Mature Neurology and Allergy Portfolio in China for $680M

10 months ago talkbio0Tagged CBC Group, China, Complete Blood Count, innovation, Mubadala, Neurology speciality, strategic partnerships, UCB

UCB, China, neurology, allergy, divestment, CBC Group, Mubadala, pharmaceuticals, innovation, strategic partnerships

Vertex Pharmaceuticals Sues US Government Over Fertility Assistance Program for Gene Therapy Patients

11 months ago talkbio0Tagged Biologic Preservation, Fertility, gene therapy, Government, Health Insurance

Vertex Pharmaceuticals, gene therapy, fertility assistance program, lawsuit, US government, health insurance, fertility preservation

US FTC Intensifies Patent Crusade with Investigation into Teva’s Inhaler IP

11 months ago talkbio0Tagged anticompetitive, Evaluation, Generic competition, Immunoprecipitation, Inhaler, Practice Experience, Teva, United States Federal Trade Commission

US Federal Trade Commission, Teva Pharmaceuticals, Patent Investigation, Inhaler IP, Anticompetitive Practices, Generic Competition